You are viewing the site in preview mode
Skip to main content
| Patient characteristics | Median (min, max) |
|---|
| Age of diagnosis | 48 years (26, 61) |
| Tumor size | 5.9 cm (2.5, 11) |
| Follow-up period | 6.6 years (2.4, 10.8) |
| | n (%) |
|---|
| ER |
| Negative | 4 (27) |
| Positive | 11 (73) |
| PR |
| Negative | 4 (27) |
| Positive | 11 (73) |
| Myometrial invasion |
| Absent | 6 (40) |
| Present | 9 (60) |
| Lymphovascular invasion |
| Absent | 15 (100) |
| Present | 0 (0) |
| Sarcomatous overgrowth |
| Absent | 5 (33) |
| Present | 10 (67) |
| Lymph node involvement |
| No | 15 (100) |
| Figo stage overall |
| I | 14 (93) |
| II/III/IV | 1 (7) |
| Vital status |
| Alive | 10 (67) |
| Dead | 5 (33) |
| Disease-free survival status |
| Disease-free | 9 (60) |
| Disease recurred | 6 (40) |
| Local recurrence-free survival status |
| Local recurrence-free | 10 (67) |
| Local recurrence | 5 (33) |
